Atlas Partners with InSilico Medicine to Work on Cell Regeneration
WINSTON SALEM, NC: As an organism ages, its productivity diminishes making it weak and vulnerable. Scientists have been trying out new methods to restructure these aged cells or prevent aging from a very long time. It is into this scenario that the new partnership of Atlas Regeneration and InSilico Medicine enters, which utilizes the Geroscope platform to rate the anti-aging therapies and determine the widely used new drugs that promises longevity.
Aging is a complex multifactorial process often considered beyond control; and that brings stress into the human life. Atlas Regeneration believes otherwise and is working on discovering methods to retain people with same productivity even as the age increases. But simple drug combinations do not realize the goal; instead it requires treatments tailored to each individual disposition.
Additionally, the company understands the scope of Stem Cell technology and focuses on possible regeneration-inducing drugs to slow down the aging process by stimulating natural tissue regenerating potential. These drugs having anti-inflammation, regeneration and geroprotective influence are slowly getting their due attention, even though they have been known since decades. Many more drugs that can potentially solve the aging problems are still left unnoticed.
There are also challenges in the field. For instance, iPSC technology, one of the technologies used for treating aging, , is not completely safe and has differentiation limitations. For the same reason the company’s bio informatics platform undergoes the following checks: analyzes available omics profiles of ‘cells-in-progress’ and its counterparts in healthy tissues; computer simulations to see which treatment on old cell brings it back to normal/healthy tissue; validating the results on human cells or model organisms.
By James Seevers, CIO & GM, Toyoda Gosei
By Bill Krivoshik, SVP & CIO, Time Warner Inc.
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Bruce. D. Smith, SVP & CIO, Information Systems, Advocate...
By Adrian Mebane, VP-Global Ethics & Compliance, The Hershey...
By Graham Welch, Director-Cisco Security, Cisco
By Michael Watkins, Senior Product Director, Global Knowledge
By Bernd Schlotter, President of Services, Unify
By Patrick Hale, CIO, VITAS Healthcare
By Steve Bein, VP-GIS, Michael Baker International
By Jason Alan Snyder, CTO, Momentum Worldwide
By Mike Morris, CIO, Legends
By Louis Carr, Jr., CIO, Clark County
By Bill Dow, SVP and General Manager of Business Solutions,...
By Jim Whitehurst, CEO, Red Hat
By Darren Cockrel, CIO, Coyote Logistics, a UPS Company...
By Nathan Johnson, SVP and CIO, Werner Enterprises [NASDAQ:...
By David Tamayo, CIO, DCS Corporation
By Neil Hampshire, CIO, ModusLink Global Solutions, Inc....